CLEW offers real-time AI analytics platforms that enable healthcare providers to make informed clinical decisions by predicting life-threatening complications across diverse medical care settings. CLEW's goal is to provide advanced solutions to enhance outcomes and safety, optimize patient care, and effectively manage regulations and penalties, ultimately reducing cost of care. With its roots in the ICU, CLEW leverages its expertise in developing machine learning models to optimize clinical resources and assist providers in predicting patient deterioration across all care settings. By leveraging cutting-edge technology, CLEW is committed to driving healthcare innovation and delivering transformative results for patients and providers alike.

EchoCare offers a remote wellness monitoring system for seniors who live independently at home or assisted living facilities. The non-wearable, non-invasive system tracks the daily activities (ADL) to indicate on a significate deviation that might increase the risk for acute situations such as falls or health deterioration. It also detects acute situations, such as falling, respiratory distress and other abnormal situations that need an early intervention. The proprietary radar-based system with its enhanced AI/ML engines is connected to the cloud to enable remote access to the dashboard, mobile application and connectivity to third-party systems. EchoCare partners with remote patient and senior care service providers to offer superior monitoring capabilities, promoting the benefits of homecare without privacy invasion.

TechnoPulm is shifting the Pulmonary Functional test paradigm. By using the Technopulm STS handheld device, Pulmonary Functional Tests can be performed in the community and avoid the need of sending patients to the hospital to By have respiratory disease diagnostics. Technopulm completed the product development with a successful a clinical trial on 161 subjects at Kaplan Hospital, holding granted patents in the US and Europe, completed the quality assurance system that complies with the ISO 13845 standard, and finalized the submission files to the FDA/CE. These days TechnoPulm is conducting a clinical pilot jointly with two leading HMOs in Israel to diagnose lung diseases from the community and is working to create collaborations in the United States and Europe.